By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ILEX Oncology, Inc. 

4545 Horizon Hill Boulevard

San Antonio  Texas  78229-2263  U.S.A.
Phone: 210-949-8200 Fax: 210-949-8210


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology

Collaborations

Millennium: The Takeda Oncology Company  Development of CAMPATH.

Schering AG  Together with Millennium Pharmaceuticals, Inc., ILEX has entered into a distribution and development agreement with Schering AG to market CAMPATH worldwide except for Japan and East Asia.

IMPATH Inc.  ILEX's strategic relationship with IMPATH, Inc. is focused on enhancing the Company's clinical trial design capabilities.

Symphar S.A.  Development of APOMINE (SR-45023A).





Company News
Genzyme Corporation (GENZ) Completes Acquisition Of ILEX Oncology, Inc. (GENZ)10/19/2005 5:12:30 PM
Additional Patients Support Clofarabine Promise; ILEX Oncology, Inc. (ILXO) Expects FDA Decision On NDA Filing By Year End 10/19/2005 5:12:23 PM
Bioenvision (BIOV) Release: Clofarabine Achieves High Response Rates In Acute Myeloid Leukaemia -AML-; Three Fold Increase In Response Rates Compared With Current Standard Of Care10/19/2005 5:12:22 PM
ILEX Oncology, Inc. (ILXO) Drug Helps One Leukemia, Not Another -US Panel10/19/2005 5:12:21 PM
ILEX Oncology, Inc. (ILXO) Release: FDA Advisory Committee Recommends Accelerated Clofarabine Approval For Most Common Pediatric Leukemia10/19/2005 5:12:20 PM
FDAAdvisoryCommittee.com To Webcast Dec. 1-2 Reviews Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa, ILEX Oncology, Inc.' (ILXO) Clolar For Leukemia, And INEX Pharmaceuticals (IEX.TO) / Enzon Pharmaceuticals, Inc.'s (ENZN) Marqibo For Lymphoma10/19/2005 5:12:19 PM
ILEX Oncology (ILXO) Reports Q3 2004 Results; Clofarabine FDA Panel Hearing Set For December10/19/2005 5:11:52 PM
Berlex Inc. And ILEX Oncology (ILXO) Release: CAMPATH(R) (Alemtuzumab For Injection) Approved For Marketing In New Single-Use Vial10/19/2005 5:11:51 PM
Bioenvision's (BIOV) Clofarabine Data Presented At Leading Hematology Congress; Durable Responses Reported At Leukemia 2004 Houston, Texas10/19/2005 5:11:49 PM
ILEX Oncology (ILXO) Updates Clofarabine NDA With Encouraging Results; Additional Patient Data Resets FDA Action Date10/19/2005 5:11:41 PM
12345
//-->